You still think about food
Lancet Diabetes Endocrinol 2021;9:65362.ArticlePubMed 75
14.2 Monotherapy Use of Semaglutide Tablets in Patients with Type 2 Diabetes Mellitus In a 26-week double-blind trial (Trial 1, NCT02906930), 703 adult patients with type 2 diabetes mellitus inadequately controlled with diet and exercise were randomized to semaglutide tablets 3 mg, semaglutide tablets 7 mg or semaglutide tablets14 mg orally once daily or placebo
doi:10.1038/cdd.2009.107, PMID: 19662025 Balaban RS, Nemoto S, Finkel T (2005) Mitochondria, oxidants, and aging
Liver: In the ESSENCE Phase 3 trial, 62.9% of patients on semaglutide achieved resolution of steatohepatitis without worsening fibrosis, versus 34.1% on placebo
See what works for you